Protocol Ledger

NCT04323800 · Phase II · COMPLETED

Convalescent Plasma to Stem Coronavirus (CSSC-001)

Interventional Phase II clinical trial protocol NCT04323800 sponsored by Johns Hopkins University in Infectious Disease and Vaccines, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-06-10 Enrollment: 180 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04323800
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)180 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04323800
Protocol FieldVerified Registry Value
NCT IdentifierNCT04323800
Consolidated Lead SponsorJohns Hopkins University
Therapeutic Condition CohortInfectious Disease and Vaccines
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment180 participants (ACTUAL)
Registered Start Date2020-06-10
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Johns Hopkins Medicine across sibling Meru public-data platforms.

Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI